These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 24271471)
1. Development of Interferon Suppositories. I. Enhanced Rectal Absorption of Human Fibroblast Interferon by Fusogenic Lipid via Lymphotropic Delivery in Rats. Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S Pharm Res; 1986 Apr; 3(2):116-7. PubMed ID: 24271471 [TBL] [Abstract][Full Text] [Related]
2. Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats. Yoshikawa H; Takada K; Satoh Y; Naruse N; Muranishi S Pharm Res; 1985 Sep; 2(5):249-50. PubMed ID: 24272847 [TBL] [Abstract][Full Text] [Related]
3. A method to potentiate enteral absorption of interferon and selective delivery into lymphatics. Yoshikawa H; Takada K; Muranishi S; Satoh Y; Naruse N J Pharmacobiodyn; 1984 Jan; 7(1):59-62. PubMed ID: 6726613 [TBL] [Abstract][Full Text] [Related]
4. The mode of enhanced enteral absorption of macromolecules by lipid-surfactant mixed micelles. I. Masuda Y; Yoshikawa H; Takada K; Muranishi S J Pharmacobiodyn; 1986 Oct; 9(10):793-8. PubMed ID: 3820056 [TBL] [Abstract][Full Text] [Related]
5. Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles. Takada K; Shibata N; Yoshimura H; Masuda Y; Yoshikawa H; Muranishi S; Oka T J Pharmacobiodyn; 1985 Apr; 8(4):320-3. PubMed ID: 4032221 [TBL] [Abstract][Full Text] [Related]
6. Effect of absorption promoters in intranasal administration of human fibroblast interferon as a powder dosage form in rabbits. Igawa T; Maitani Y; Machida Y; Nagai T Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):418-21. PubMed ID: 2743486 [TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of human fibroblast interferon in mice, rats, rabbits and dogs. Igawa T; Maitani Y; Machida Y; Nagai T Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):549-51. PubMed ID: 2337971 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability and diuretic effect of bumetanide following rectal administration of suppositories containing weak acids in human subjects. Yagi N; Kenmotsu H; Shimode Y; Oda K; Sekikawa H; Takada M Biol Pharm Bull; 1993 Nov; 16(11):1124-9. PubMed ID: 8312869 [TBL] [Abstract][Full Text] [Related]
9. Comparison of disappearance from blood and lymphatic delivery of human fibroblast interferon in rat by different administration routes. Yoshikawa H; Satoh Y; Naruse N; Takada K; Muranishi S J Pharmacobiodyn; 1985 Mar; 8(3):206-10. PubMed ID: 4009412 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of human fibroblast interferon in rats]. Satoh Y; Kasama K; Usuki K; Naruse N; Ida N Gan To Kagaku Ryoho; 1984 Feb; 11(2):301-6. PubMed ID: 6696463 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of antitumor effect of bleomycin by lipid-surfactant mixed micelles. I. In vivo and tumor-neutralizing activity against mouse Ehrlich ascites tumor and rat ascites hepatoma AH66. Yoshikawa H; Takada K; Muranishi S J Pharmacobiodyn; 1985 Apr; 8(4):305-10. PubMed ID: 2411907 [TBL] [Abstract][Full Text] [Related]
12. [Enhancement of rectal absorption of rifampicin by sodium para-aminosalicylate dihydrate in human subjects]. Suzuki R; Nakajima Y; Yagi N; Kenmotsu H; Sekikawa H; Miyazaki S; Mino K; Ohwada S; Kishi F; Hayashi N Yakugaku Zasshi; 1994 Nov; 114(11):894-900. PubMed ID: 7853151 [TBL] [Abstract][Full Text] [Related]
13. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits. Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920 [TBL] [Abstract][Full Text] [Related]
14. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats. Kim JY; Ku YS Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687 [TBL] [Abstract][Full Text] [Related]
15. Absorption of new HIV-1 protease inhibitor, KNI-272, after intraduodenal and intragastric administrations to rats: effect of solvent. Sugahara M; Kiriyama A; Hamada Y; Kiso Y; Takada K Biopharm Drug Dispos; 1995 May; 16(4):269-77. PubMed ID: 7548776 [TBL] [Abstract][Full Text] [Related]
16. Characterization of E. coli-derived recombinant human interferon-beta as compared with fibroblast human interferon-beta. Utsumi J; Yamazaki S; Hosoi K; Kimura S; Hanada K; Shimazu T; Shimizu H J Biochem; 1987 May; 101(5):1199-208. PubMed ID: 3308862 [TBL] [Abstract][Full Text] [Related]
17. Enhanced absorption of bumetanide from suppositories containing weak acids in rabbits. Yagi N; Kenmotsu H; Shimode Y; Oda K; Sekikawa H; Takada M Biol Pharm Bull; 1993 Mar; 16(3):263-7. PubMed ID: 8364470 [TBL] [Abstract][Full Text] [Related]
18. Improvement by adjuvants on the rectal bioavailability of non-absorbable drugs following administration of suppository. Nakanishi K; Masada M; Nadai T J Pharmacobiodyn; 1990 Dec; 13(12):760-5. PubMed ID: 2098548 [TBL] [Abstract][Full Text] [Related]
19. Effect of oxyethylene moieties in hydrogenated castor oil on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oil and soybean oil in rats. Ueda K; Yamazaki Y; Noto H; Teshima Y; Yamashita C; Sakaeda T; Iwakawa S J Drug Target; 2003 Jan; 11(1):37-43. PubMed ID: 12852439 [TBL] [Abstract][Full Text] [Related]
20. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin. Watanabe Y; Mizufune Y; Kubomura A; Kiriyama M; Utoguchi N; Matsumoto M Biol Pharm Bull; 1998 Nov; 21(11):1187-90. PubMed ID: 9853410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]